Thermo Fisher Scientific Inc. (TMO) financials
Thermo Fisher Scientific Inc. (TMO) revenue, EBIT and EBITDA, earnings per share, free cash flow, margins, debt and shareholders equity — annual and quarterly history, charted from SEC filings. No account needed.
In fiscal 2025, Thermo Fisher Scientific Inc. reported revenue of $44.56B, up 3.9% year over year, net income of $6.70B, diluted EPS of $17.74 and free cash flow of $6.29B.
- Revenue (fiscal 2025)
- $44.56B
- Revenue growth (fiscal 2025)
- 3.9%
- Net income (fiscal 2025)
- $6.70B
- Diluted EPS (fiscal 2025)
- $17.74
- Free cash flow (fiscal 2025)
- $6.29B
Thermo Fisher Scientific Inc. files with the U.S. Securities and Exchange Commission under CIK 0000097745, classified as Measuring & Controlling Devices, NEC.
Explore annual and quarterly revenue, earnings, cash flow, margins, debt and equity from SEC filings.